Kidney Disease Clinical Trials

Showing 1561-1580 of 3,346 trials

Study to Assess the Safety and Pharmacokinetics of AKB-6548 in Participants With Chronic Kidney Disease (CKD), Stages 3 and 4

NCT04707573

This study was conducted to assess the pharmacokinetic (PK) profile, safety, and tolerability in participants with Stage 3 and 4 Chronic Kidney Disease (CKD) following a single oral dose of Vadadustat.

Chronic Kidney Disease

Akebia Therapeutics22 participantsStarted Jul 2010

Saint Paul, Minnesota, United States • Knoxville, Tennessee, United States

COMPLETEDPhase 3

Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease

NCT02648347

A multicenter, randomized, open-label, active-controlled Phase 3 study for the correction of anemia and maintenance of hemoglobin (Hb) in participants with Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)

AnemiaNon-Dialysis-Dependent Chronic Kidney Disease

Akebia Therapeutics1,751 participantsStarted Dec 2015

Huntsville, Alabama, United States • Tuscumbia, Alabama, United States • Glendale, Arizona, United States +436 more locations

Study to Assess the Safety and Pharmacokinetics of AKB-6548 in Participants With Chronic Kidney Disease (CKD), Stages 3 and 4

Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease

Related Searches

Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression

Pilot Study of Loop Diuretics Among Individuals Receiving Hemodialysis

Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis

Food Effect Study of DDO-3055 Tablets in Healthy Subjects

End-Stage Kidney Disease Interactive Decision Aid for the Elderly (myKIDNEY)

Outcome of Glargine Insulin in Renal Impairment Patients With Diabetic Ketoacidosis

The Effect of Food Intake During Hemodialysis on Blood Pressure

Relationship Between Serum 1,25-dihydroxy Vitamin D and Markers of Bone Metabolism in Renal Dysfunction Patients

Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction

Normotonic Partial Nephrectomy as Novel Approach in Treating Small Renal Masses

Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101

Continuous Glucose Monitoring and Inflammation in Nondiabetic and Diabetic Patients Undergone Hemodialysis

Treatment of Obstructive Sleep Apnea in Chronic Kidney Disease

Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism

Metabolite Biomarkers Related to Acute Rejection in Kidney Transplantation

Kidney Precision Medicine Project

Review of Trend in Incidence and Characteristics of Hospital-acquired Acute Kidney Injury in Hospital Selayang

Effects of Green Propolis Extract (EPP-AF) on Inflammation in Hemodialysis Patients.